Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Long Term Remission Achieved By Fostamatinib in ITP: A Case Report

Waleed Ghanima, MD PhD, Tjønnfjord Eirik, MD PhD

Blood (2019) 134 (Supplement_1): 4901.

https://doi.org/10.1182/blood-2019-128359

Published: 2019

Journal Articles

Management and Outcome of 11 Pregnancies in Women with Polycythemia Vera

Elena Maria Elli, MD, Rossella Calori, MD, Ida Carmosino, Massimo Breccia, MD, Elisa Diral, MD, Carlo Gambacorti-Passerini, MD, Ambra Di Veroli, MD, Roberto Latagliata

Blood (2018) 132 (Supplement 1): 5471.

https://doi.org/10.1182/blood-2018-99-119663

Published: 2018

Journal Articles

Efficacy and Safety of First-Line Therapy with Chlorambucil, Rituximab and Individualized Dose Lenalidomide in FCR-Unfit Patients with Advanced Chronic Lymphocytic Leukemia (CLL): A Phase I/II HOVON Trial

Blood (2017) 130 (Supplement 1): 4328.

https://doi.org/10.1182/blood.V130.Suppl_1.4328.4328

Published: 2017

Journal Articles

Poor Responsiveness to Low-Dose Aspirin Contributes to Persistent In Vivo Platelet Activation in Polycythemia Vera

Paola Ranalli, MD, Giovanna Petrucci, PhD, Alfredo Dragani, MD, Mauro Di Ianni, MD PhD, Paolo Di Bartolomeo, MD, Viviana Cavalca, BSc, Benedetta Porro, PhD, Elena Tremoli, PhD, Carlo Patrono, MD, Bianca Rocca, MD

Blood (2017) 130 (Supplement 1): 2379.

https://doi.org/10.1182/blood.V130.Suppl_1.2379.2379

Published: 2017

Journal Articles

Bortezomib-Based Regimens As Consolidation Therapy after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Single Center Experience from Oran (Algeria)

Souad Talhi, MD, Soufi Osmani, MD, Mohamed Brahimi, MD PhD, Kamila Amani, MD, Hafida Ouldjeriouat, MD, Samira Bouchama, MD, Leila Charef, MD, Mohamed Amine Mazari, MD, Badra Entasoltan, MD, Nabil Yafour, MD, Amina Krim, MD, Rachid Amar Bouhass, MD PhD, Abdessamed Arabi, MD PhD, Mohamed Amine Bekadja

Blood (2016) 128 (22): 5121.

https://doi.org/10.1182/blood.V128.22.5121.5121

Published: 2016

Journal Articles

Phase I/II Trial of Weekly Escalated Dose Bortezomib Combined with Lenalidomide and Dexamethasone in Patients in First Relapse or Primary Refractory Disease after First Line Therapy for Multiple Myeloma

Annemiek Broijl, MDPhD, Marie José Kersten, MD PhD, Wendim Ghidey Alemayehu, PhD, Mark-David Levin, MDPhD, Okke de Weerdt, MD, Edo Vellenga, MDPhD, Ellen Meijer, MDPhD, Shulamiet Wittebol, MDPhD, Rosita Ghiraw-Visser, Marian Stevens-Kroef, PhD, Berna Beverloo, PhD, Gerard M.J. Bos, MDPhD, Pierre W. Wijermans, MDPhD, Henk Lokhorst, MDPhD, Pieter Sonneveld, MDPhD

Blood (2014) 124 (21): 4735.

https://doi.org/10.1182/blood.V124.21.4735.4735

Published: 2014

Journal Articles

Aspirin Hybrid Molecules with Improved Antiplatelet Properties Designed As New Drug Candidates to Prevent Atherothrombosis,

Jean Leandro Santos, B.Sc., M.Sc., Ph, D, Ednir Vizioli de Oliveira, B.Sc., M.Sc., Ph, D, Maria Elisa Lopes Pires, B.Sc., M.Sc., Thais Regina Ferreira de Melo, B.Sc., Fernando Ferreira Costa, MD, PhD, Chung Man Chin, B.Sc., M.Sc., Ph, D

Blood (2011) 118 (21): 3364.

https://doi.org/10.1182/blood.V118.21.3364.3364

Published: 2011

Journal Articles

Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation

Pavel Uhrin, Jan Zaujec, Johannes M. Breuss, Damla Olcaydu, Peter Chrenek, Hannes Stockinger, Elke Fuertbauer, Markus Moser, Paula Haiko, Reinhard Fässler, Kari Alitalo, Bernd R. Binder, Dontscho Kerjaschki

Blood (2010) 115 (19): 3997–4005.

https://doi.org/10.1182/blood-2009-04-216069

Published: 2010

Includes: Supplemental data

Journal Articles

Absence of Pharmacodynamic or Pharmacokinetic Interactions When TAK-442, An Oral, Direct Factor Xa Inhibitor, Is Coadministered with Aspirin or Clopidogrel.

Fran Stringer, Graham Scott, Stuart Kupfer, Charlie Cao, Ph.D., Masaki Kawamura, DVM, PhD

Blood (2009) 114 (22): 4175.

https://doi.org/10.1182/blood.V114.22.4175.4175

Published: 2009

Journal Articles

Targeting the Protein Phosphatase, Shp2, Reduces FLT3-ITD-Induced Hyperproliferation of Murine Hematopoietic Progenitors.

Sarah C Nabinger, Yantao He, Fuqin Yin, Xian Zhang, Linda Senbanjo, Seiji Fukuda, MD, PhD, Menggang Yu, Gen-Sheng Feng, Zhong-Yin Zhang, Reuben Kapur, PhD, Rebecca J. Chan, MD, PhD

Blood (2009) 114 (22): 827.

https://doi.org/10.1182/blood.V114.22.827.827

Published: 2009

Journal Articles

Aspirin and Aspirin Combined with Low-Molecular-Weight Heparin in Women with Unexplained Recurrent Miscarriage: a Randomized Controlled Multicenter Trial (ALIFE Study).

Stef P. Kaandorp, MD, Mariëtte Goddijn, MD, PhD, Joris A.M. van der Post, MD, PhD, Barbara A. Hutten, PhD, Harold R. Verhoeve, MD, Karly Hamulyak, MD, PhD, Ben-Willem Mol, MD, PhD, Nienke Folkeringa, MD, PhD, Marleen Nahuis, MD, Dimitri Papatsonis, MD, PhD, Harry R. Buller, MD, PhD, Fulco van der Veen, MD, PhD, Saskia Middeldorp, MD, PhD

Blood (2009) 114 (22): 488.

https://doi.org/10.1182/blood.V114.22.488.488

Published: 2009

Journal Articles

The Para-Isomer of Nitric Oxide-Donating Acetylic Salicylic Acid (p-NO-ASA) Effectively Induces Cell Death in B-Cell Chronic Lymphocytic Leukemia (CLL) Cells at Low Micromolar Concentrations.

Regina Razavi, M.Pharm., Julian Paesler, M.Pharm., Iris Gehrke, M.Sc., Felix Erdfelder, Magdalena Hertweck, Alexandra Filipovich, Rajesh Kumar Gandhirajan, M.Sc., Michael Hallek, MD, Karl Anton Kreuzer, M.D.

Blood (2008) 112 (11): 1606.

https://doi.org/10.1182/blood.V112.11.1606.1606

Published: 2008

Journal Articles

Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB–regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBα kinase, leading to potentiation of apoptosis

Bokyung Sung, Manoj K. Pandey, Kwang Seok Ahn, Tingfang Yi, Madan M. Chaturvedi, Mingyao Liu, Bharat B. Aggarwal

Blood (2008) 111 (10): 4880–4891.

https://doi.org/10.1182/blood-2007-10-117994

Published: 2008

Journal Articles

Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/β-thalassemia patient

Vichai Atichartakarn, Suporn Chuncharunee, Pakorn Chandanamattha, Khanchit Likittanasombat, Katcharin Aryurachai

Blood (2004) 103 (7): 2844–2846.

https://doi.org/10.1182/blood-2003-09-3094

Published: 2004

Journal Articles

Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals

Minenori Eguchi-Ishimae, Mariko Eguchi, Eiichi Ishii, Sumio Miyazaki, Kazuhiro Ueda, Nanao Kamada, Shuki Mizutani

Blood (2001) 97 (3): 737–743.

https://doi.org/10.1182/blood.V97.3.737

Published: 2001

Journal Articles

Reperfusion injury pathophysiology in sickle transgenic mice

U. Raymond Osarogiagbon, Stephana Choong, John D. Belcher, Gregory M. Vercellotti, Mark S. Paller, Robert P. Hebbel

Blood (2000) 96 (1): 314–320.

https://doi.org/10.1182/blood.V96.1.314

Published: 2000

NARROW

Long Term Remission Achieved By Fostamatinib in ITP: A Case Report

Management and Outcome of 11 Pregnancies in Women with Polycythemia Vera

Efficacy and Safety of First-Line Therapy with Chlorambucil, Rituximab and Individualized Dose Lenalidomide in FCR-Unfit Patients with Advanced Chronic Lymphocytic Leukemia (CLL): A Phase I/II HOVON Trial

Poor Responsiveness to Low-Dose Aspirin Contributes to Persistent In Vivo Platelet Activation in Polycythemia Vera

Bortezomib-Based Regimens As Consolidation Therapy after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Single Center Experience from Oran (Algeria)

Phase I/II Trial of Weekly Escalated Dose Bortezomib Combined with Lenalidomide and Dexamethasone in Patients in First Relapse or Primary Refractory Disease after First Line Therapy for Multiple Myeloma

Aspirin Hybrid Molecules with Improved Antiplatelet Properties Designed As New Drug Candidates to Prevent Atherothrombosis,

Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation

Absence of Pharmacodynamic or Pharmacokinetic Interactions When TAK-442, An Oral, Direct Factor Xa Inhibitor, Is Coadministered with Aspirin or Clopidogrel.

Targeting the Protein Phosphatase, Shp2, Reduces FLT3-ITD-Induced Hyperproliferation of Murine Hematopoietic Progenitors.

Aspirin and Aspirin Combined with Low-Molecular-Weight Heparin in Women with Unexplained Recurrent Miscarriage: a Randomized Controlled Multicenter Trial (ALIFE Study).

The Para-Isomer of Nitric Oxide-Donating Acetylic Salicylic Acid (p-NO-ASA) Effectively Induces Cell Death in B-Cell Chronic Lymphocytic Leukemia (CLL) Cells at Low Micromolar Concentrations.

Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/β-thalassemia patient

Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals

Reperfusion injury pathophysiology in sickle transgenic mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only